Communicating the Value of Pharmacodynamic Modelling in Drug ...

Concluding Remarks
Modeling provides the means for integrating knowledge and using it for
quantitative decision-making.
Exposure – response models are key to allow extrapolation to other
populations and to designing further studies.
Clinical information about previously developed drugs may be exploited to
develop models for predicting clinical outcomes.
Such prior knowledge (prior information + models) can be exploited to
accelerate clinical development.
M&S can be exploited to answer important clinical questions; appropriate
display of the results is critical to information transfer and decisionmaking
within clinical teams.
slide 44
30 May 2008, ARCS
© Pharsight Corporation All Rights Reserved